Donoghue Helen D, Michael Taylor G, Marcsik Antónia, Molnár Erika, Pálfi Gyorgy, Pap Ildikó, Teschler-Nicola Maria, Pinhasi Ron, Erdal Yilmaz S, Velemínsky Petr, Likovsky Jakub, Belcastro Maria Giovanna, Mariotti Valentina, Riga Alessandro, Rubini Mauro, Zaio Paola, Besra Gurdyal S, Lee Oona Y-C, Wu Houdini H T, Minnikin David E, Bull Ian D, O'Grady Justin, Spigelman Mark
Centre for Clinical Microbiology, Division of Infection and Immunity, University College London, UK.
Department of Microbial and Cellular Science, Faculty of Health and Medical Sciences, University of Surrey, Guildford, Surrey, UK.
Infect Genet Evol. 2015 Apr;31:250-6. doi: 10.1016/j.meegid.2015.02.001. Epub 2015 Feb 11.
Leprosy was rare in Europe during the Roman period, yet its prevalence increased dramatically in medieval times. We examined human remains, with paleopathological lesions indicative of leprosy, dated to the 6th-11th century AD, from Central and Eastern Europe and Byzantine Anatolia. Analysis of ancient DNA and bacterial cell wall lipid biomarkers revealed Mycobacterium leprae in skeletal remains from 6th-8th century Northern Italy, 7th-11th century Hungary, 8th-9th century Austria, the Slavic Greater Moravian Empire of the 9th-10th century and 8th-10th century Byzantine samples from Northern Anatolia. These data were analyzed alongside findings published by others. M. leprae is an obligate human pathogen that has undergone an evolutionary bottleneck followed by clonal expansion. Therefore M. leprae genotypes and sub-genotypes give information about the human populations they have infected and their migration. Although data are limited, genotyping demonstrates that historical M. leprae from Byzantine Anatolia, Eastern and Central Europe resembles modern strains in Asia Minor rather than the recently characterized historical strains from North West Europe. The westward migration of peoples from Central Asia in the first millennium may have introduced different M. leprae strains into medieval Europe and certainly would have facilitated the spread of any existing leprosy. The subsequent decline of M. leprae in Europe may be due to increased host resistance. However, molecular evidence of historical leprosy and tuberculosis co-infections suggests that death from tuberculosis in leprosy patients was also a factor.
麻风病在罗马时期的欧洲很罕见,但在中世纪其患病率急剧上升。我们研究了来自中欧、东欧和拜占庭安纳托利亚的公元6至11世纪的人类遗骸,这些遗骸有指示麻风病的古病理损伤。对古代DNA和细菌细胞壁脂质生物标志物的分析揭示,在意大利北部6至8世纪、匈牙利7至11世纪、奥地利8至9世纪、9至10世纪的斯拉夫大摩拉维亚帝国以及安纳托利亚北部8至10世纪的拜占庭样本的骨骼遗骸中发现了麻风分枝杆菌。这些数据与其他人发表的研究结果一起进行了分析。麻风分枝杆菌是一种专性人类病原体,经历了进化瓶颈,随后进行了克隆扩增。因此,麻风分枝杆菌的基因型和亚基因型提供了有关它们所感染的人群及其迁移情况的信息。尽管数据有限,但基因分型表明,来自拜占庭安纳托利亚、东欧和中欧的历史上的麻风分枝杆菌与小亚细亚的现代菌株相似,而不是与最近在西北欧鉴定出的历史菌株相似。公元一千年中亚民族的西迁可能将不同的麻风分枝杆菌菌株引入了中世纪的欧洲,而且肯定促进了任何现有麻风病的传播。随后欧洲麻风分枝杆菌的减少可能是由于宿主抵抗力增强。然而,历史上麻风病和结核病合并感染的分子证据表明,麻风病患者死于结核病也是一个因素。